RDMD – Patient Worthy

Source: Pixabay.com

RDMD Gets $14 Million in Financing, Partners with UCB to Research Progressive Supranuclear Palsy

Post author:Jessica Lynn
Post published:April 30, 2020
Post category:Neurofibromatosis Neurofibromatosis Type 2 Progressive Supranuclear Palsy Rare Disease Sanfilippo Syndrome

According to BioSpace, healthcare technology company RDMD has raised $14 million in Series A financing, and developed a partnership with UCB. In addition to growing their platform to discuss…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More